help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0271
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/7/1918    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, Y.
Right arrow Articles by Papadopoulos, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Y.
Right arrow Articles by Papadopoulos, V.
Molecular Endocrinology 19 (7): 1918-1931
Copyright © 2005 by The Endocrine Society

Cytochrome P450 17{alpha} Hydroxylase/17,20 Lyase (CYP17) Function in Cholesterol Biosynthesis: Identification of Squalene Monooxygenase (Epoxidase) Activity Associated with CYP17 in Leydig Cells

Ying Liu, Zhi-Xing Yao and Vassilios Papadopoulos

Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, D.C. 20057

Address all correspondence and requests for reprints to: Vassilios Papadopoulos, Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, 3900 Reservoir Road Northwest, Washington, D.C. 20057. E-mail: papadopv{at}georgetown.edu.

Cytochrome P450 17{alpha}-hydroxylase/17,20-lyase (CYP17) is a microsomal enzyme catalyzing two distinct activities, 17{alpha}-hydroxylase and 17,20-lyase, essential for the biosynthesis of adrenal and gonadal steroids. CYP17 is a potent oxidant, it is present in liver and nonsteroidogenic tissues, and it has been suggested to have catalytic properties distinct to its function in steroid metabolism. To identify CYP17 functions distinct of its 17{alpha}-hydroxylase/17,20-lyase activity, we used MA-10 mouse tumor Leydig cells known to be defective in 17{alpha}-hydroxylase/17,20-lyase activity. A CYP17 knocked down MA-10 clone (MA-10CYP17KD) was generated by homologous recombination and its steroidogenic capacity was compared with wild-type cells (MA-10wt). Although no differences in cell morphology and proliferation rates were observed between these cells, the human chorionic gonadotropin-induced progesterone formation and de novo synthesis of steroids were dramatically reduced in MA-10CYP17KD cells; their steroidogenic ability could be rescued in part by transfecting CYP17 DNA into the cells. Knocking down CYP17 mRNA by RNA interference yielded similar results. However, no significant difference was observed in the steroidogenic ability of cells treated with 22R-hydroxycholesterol, which suggested a defect in cholesterol biosynthesis. Incubation of MA-10CYP17KD cells with 14C-labeled squalene resulted in the formation of reduced amounts of radiolabeled cholesterol compared with MA-10wt cells. In addition, treatment of MA-10CYP17KD cells with various cholesterol substrates indicated that unlike squalene, addition of squalene epoxide, lanosterol, zymosterol, and desmosterol could rescue the hormone-induced progesterone formation. Further in vitro studies demonstrated that expression of mouse CYP17 in bacteria resulted in the expression of squalene monooxygenase activity. In conclusion, these studies suggest that CYP17, in addition to its 17{alpha}-hydroxylase/17,20-lyase activity, critical in androgen formation, also expresses a secondary activity, squalene monooxygenase (epoxidase), of a well-established enzyme involved in cholesterol biosynthesis, which may become critical under certain conditions.




This article has been cited by other articles:


Home page
J AndrolHome page
Y. Liu, L. E. Dettin, J. Folmer, B. R. Zirkin, and V. Papadopoulos
Abnormal Morphology of Spermatozoa in Cytochrome P450 17{alpha}-hydroxylase/17, 20-lyase (CYP17) Deficient Mice
J Androl, May 1, 2007; 28(3): 453 - 460.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Liu, Z.-X. Yao, C. Bendavid, C. Borgmeyer, Z. Han, L. R. Cavalli, W.-Y. Chan, J. Folmer, B. R. Zirkin, B. R. Haddad, et al.
Haploinsufficiency of Cytochrome P450 17{alpha}-Hydroxylase/17,20 Lyase (CYP17) Causes Infertility in Male Mice
Mol. Endocrinol., September 1, 2005; 19(9): 2380 - 2389.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society